Rare FNIP1 mutation protects against obesity, cuts heart disease risk 60%

AI digestMimile.ai EditorialAugust 11, 2026 at 07:14 AM

This digest was compiled by AI from multiple sources — links to the originals are below.

Rare FNIP1 mutation protects against obesity, cuts heart disease risk 60%

A rare mutation in the FNIP1 gene provides natural protection against obesity, reduced liver fat, and a 60% lower risk of heart disease, according to a study that sequenced over one million people. The mutation, found in about one in 7,000 individuals, was linked to healthier blood sugar levels and better fat distribution. The findings were published in Nature.

The Rare Mutation

Researchers analyzed exomes from over one million individuals to identify rare genetic variants linked to metabolic health. They pinpointed 59 genes involved in energy expenditure, storage, and burning. The most striking finding was the FNIP1 gene, which normally acts as a brake on calorie burning. About one in 7,000 people carry a natural mutation that disables one copy of this gene, removing the brake and boosting metabolism.

Metabolic Advantages

Carriers of the FNIP1 mutation exhibit significantly lower body fat and reduced fat accumulation in the liver. The study found they have a 60% lower risk of developing cardiometabolic diseases, including heart disease and diabetes. The mutation also correlates with healthier blood sugar levels and a more favorable distribution of adipose tissue. These benefits arise from the enhanced ability of cells to burn calories.

Treatment Prospects

The findings, published in Nature, suggest that targeting the FNIP1 pathway could yield new therapies for obesity and type 2 diabetes. By mimicking the mutation's effect, drugs might help patients burn more energy and reduce fat storage. Researchers caution that translating these genetic insights into treatments will require years of additional study.

What's Next

Clinical trials exploring FNIP1-based therapies could begin within the next few years, pending further validation in animal models. It remains unclear whether such treatments would replicate the full metabolic benefits seen in mutation carriers.

2 sources

Rare FNIP1 mutation protects against obesity, cuts heart disease risk 60%

nur.kz

Nur.kz

kz.kursiv.media

Kursiv.kz

Health

Nature study ties rare FNIP1 gene variants to 60% lower cardiometabolic disease risk

Rare FNIP1 gene variants are associated with a 60% lower risk of cardiometabolic disease, according to a Nature study analyzing 1.03 million people. The variants also correlate with reduced liver fat, lower blood sugar, and healthier fat distribution.

Health

McMaster University study finds GDF15 hormone curbs liver inflammation and fibrosis

Researchers at McMaster University have discovered that the appetite-suppressing hormone GDF15 shifts liver immune cells into a protective mode, slowing cirrhosis progression independently of calorie intake or fat loss, according to a study published in Cell Metabolism. The hormone activates a brain-to-liver signaling pathway that suppresses inflammation and reduces fibrosis, without affecting food consumption or body weight.

Science

CD99L2 mutations cause rare movement disorder in 3,000-patient study

Scientists identified mutations in the CD99L2 gene as a cause of a rare movement disorder after analyzing nearly 3,000 patients with coordination and muscle control problems. The gene, previously linked only to the immune system, was found to be essential for nerve-cell communication. The discovery offers a new target for potential therapies.

Health

Yale study links calorie restriction to lower C3 protein, slower aging

Yale researchers found that moderate calorie restriction lowered levels of the immune protein complement component 3 (C3) in 42 adults over two years. The reduction in C3, which is linked to chronic inflammation, suggests a mechanism by which calorie restriction may slow aging without severe dietary restriction.

Rare FNIP1 mutation protects against obesity, cuts heart disease risk 60%

The Rare Mutation

Metabolic Advantages

Treatment Prospects

What's Next

Read more

Read more